theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Ophthalmology

Endocrinology   

Questions discussed in this category


How often and in what way do you monitor patients who are receiving teprotumumab (Tepezza) for thyroid eye disease?
1 Answer available

Does your decision to start or continue Ozempic therapy in patients with diabetic retinopathy depend on the severity of the retinopathy?
1 Answer available

Is thyrotropin receptor antibody a good biomarker to predict development of thyroid eye disease?
1 Answer available

How do you diagnose and treat patients who develop uveitis while on bisphosphonate therapy for osteoporosis?
Are there specific features that suggest drug-induced uveitis versus de novo uveitis?
1 Answer available
19704200511847410720


Papers discussed in this category


The New England journal of medicine, 2016 Sep 15
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Related Topics in Ophthalmology

  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Melanoma/Skin Cancer
  • Pediatric Hematology/Oncology

Copyright © 2025 theMednet
All Rights Reserved.